Kristie McNealy, MD

Last week, I discussed the ongoing debate over which babies should receive Synagis, a medication which is used to prevent respiratory syncytial virus (RSV) infections in preemies and other high risk infants and toddlers.  RSV is a common respiratory virus which can have severe complications in preemies and babies with certain heart and lung conditions.  [...]